http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2613061-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K50-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 1996-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828e96a2381455f4d198d3dc6a1daa85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4232bb92bdde3b9e6eba98435ab6907c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb91b4ed44aa4566cc2774b50477635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71b8a159c57037dff800db977f2e4bf
publicationDate 1996-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2613061-A1
titleOfInvention Device for transdermal electrotransport delivery of fentanyl and sufentanil
abstract The invention provides a formulation for electrotransport delivery of an analgesic drug (e.g. fentanyl). Also provided is an improved electrotransport drug delivery system for analgesic drugs, namely fentanyl and sufentanil. The fentanyl/sufentanil is provided as a water-soluble halide salt (e.g., fentanyl hydrochloride), preferably contained in a hydrogel formulation for use in an electrotransport device (10). In accordance with the present invention, the donor electrode (22) of the electrotransport delivery device (10) is comprised of silver and the donor reservoir (26) is substantially free of supplementary chloride ion sources and contains a predetermined "excess" loading of fentanyl/sufentanil halide to prevent silver ion migration with attendant skin discoloration.
priorityDate 1995-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517

Total number of triples: 32.